AI Article Synopsis

  • Noonan syndrome (NS) is an autosomal dominant disorder linked to mutations in the PTPN11 gene, leading to symptoms such as congenital heart disease, short stature, and distinct facial features.
  • Interestingly, patients with LEOPARD syndrome (LS) have inactivating mutations in the same gene but display similar symptoms, highlighting the complexity of Shp2 signaling.
  • The study identifies "protein zero-related" (PZR) as a key protein involved in NS and LS, with its abnormal phosphorylation promoting symptoms by enhancing Shp2 activity and affecting cell migration during zebrafish gastrulation.

Article Abstract

Noonan syndrome (NS) is an autosomal dominant disorder caused by activating mutations in the PTPN11 gene encoding Shp2, which manifests in congenital heart disease, short stature, and facial dysmorphia. The complexity of Shp2 signaling is exemplified by the observation that LEOPARD syndrome (LS) patients possess inactivating PTPN11 mutations yet exhibit similar symptoms to NS. Here, we identify "protein zero-related" (PZR), a transmembrane glycoprotein that interfaces with the extracellular matrix to promote cell migration, as a major hyper-tyrosyl-phosphorylated protein in mouse and zebrafish models of NS and LS. PZR hyper-tyrosyl phosphorylation is facilitated in a phosphatase-independent manner by enhanced Src recruitment to NS and LS Shp2. In zebrafish, PZR overexpression recapitulated NS and LS phenotypes. PZR was required for zebrafish gastrulation in a manner dependent upon PZR tyrosyl phosphorylation. Hence, we identify PZR as an NS and LS target. Enhanced PZR-mediated membrane recruitment of Shp2 serves as a common mechanism to direct overlapping pathophysiological characteristics of these PTPN11 mutations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135572PMC
http://dx.doi.org/10.1128/MCB.00135-14DOI Listing

Publication Analysis

Top Keywords

leopard syndrome
8
ptpn11 mutations
8
recruitment shp2
8
pzr
7
shp2
5
pzr coordinates
4
coordinates shp2
4
shp2 noonan
4
noonan leopard
4
syndrome signaling
4

Similar Publications

Background: According to previous literature reports, PTPN11 gene variants account for approximately 50% of Noonan syndrome (NS) cases and 85% of Leopard syndrome (LS) cases. Several patients who were diagnosed with NS or LS complicated with Chiari I malformation (CIM) and/or syringomyelia have been reported to have a PTPN11 variant. However, it is not always clear whether the association between CIM and/or syringomyelia and PTPN11 variants is real or random.

View Article and Find Full Text PDF

Introduction: Granular cell tumors (GCT) are predominantly benign neoplasms composed by cells with abundant eosinophilic granular cytoplasm. Although the majority of GCTs exhibit a benign clinical course, a minority display cytological atypia and may exhibit aggressive, cancer-like behavior. Definitive evidence of malignancy in GCTs is reliably established only through the presence of metastasis.

View Article and Find Full Text PDF
Article Synopsis
  • The RASopathies are a group of genetic syndromes caused by mutations in the RAS/MAPK signaling pathway, affecting conditions like neurofibromatosis type 1, Noonan syndrome, and others, often leading to similar symptoms due to abnormal cell growth.
  • Epidermal nevus syndromes are characterized by skin nevi alongside other systemic issues, with recent findings indicating that mosaic RAS mutations may contribute to these conditions.
  • A case study details a child's treatment with the MEK inhibitor selumetinib, demonstrating stabilization of nerve hypertrophy and improvement of skin lesions, highlighting the potential for targeted therapies beyond currently established uses for RASopathy-related symptoms.
View Article and Find Full Text PDF
Article Synopsis
  • Shp2 is a vital protein that regulates cellular functions and is linked to several health issues, including obesity and cancer.
  • This research highlights Shp2's significant presence in rod photoreceptor cells and demonstrates that its absence leads to age-related degeneration of these cells.
  • The study identifies that Shp2 influences the expression of occludin, a key protein for cell junctions, and affects cell cycle regulation and retinal metabolism when deleted in rod cells.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!